Natural-born killers – and curers?
Research into snake venom pivoted from Alzheimer's disease to COVID-19 when the coronavirus reared its head.
Leader of the pharmaceutical pack
Thomas Ko is spearheading innovative technology that takes injectable medicines and transforms them into pills.
Unlocking the mysteries of coeliac disease
Vaccination may one day allow coeliac disease sufferers to have their cake and eat it, too – but many questions remain unanswered.
After a horrific 2017 flu season, there's more interest than ever in developing a better, more universal vaccine. T-cells might hold the answer.
Rahini Ragavan Kakumanu
Phd candidate, Department of Pharmacology
Research Fellow, Monash Biomedicine Discovery Institute
Associate Professor, Biochemistry and Molecular Biology
Professor and Deputy Dean (Education, Faculty of Medicine, Nursing and Health Sciences; Head, Monash Venom Research Group
Senior Research Fellow, Biochemistry & Molecular Biology